Key Trends and Insights into the Inactivated Vaccines Market: Growth Rate and Opportunities to 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the Inactivated Vaccines market?
There has been consistent growth in the size of the inactivated vaccines market in the past few years. The market is projected to grow from $6.19 billion in 2024 to reach $6.44 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.0%. The growth witnessed during the historical period can be related to the efforts to eradicate polio, initiatives for influenza vaccination, the emergence of new infectious diseases, and regulatory approvals.
What will be the inactivated vaccines market size in the future?
The market for inactivated vaccines is predicted to witness consistent growth in the coming years. The market’s worth is projected to reach $7.75 billion by 2029, with a compound annual growth rate (CAGR) of 4.7%. This growth during the forecast period is linked to readiness for pandemics, increased vaccination coverage, improvements in biomanufacturing, and initiatives on health equity. Key trends during this predicted timeframe would be mRNA vaccine platforms, combination vaccines, thermostable vaccines, and digital vaccine passports.
Get your inactivated vaccines market report here!
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
What main drivers are fueling expansion in the inactivated vaccines market?
The rise in infectious diseases is projected to accelerate the expansion of the inactivated vaccine market. Infectious diseases, induced by bacteria, viruses, fungi, or parasites, can transfer from one person to another, resulting in a variety of symptoms and health issues. Tuberculosis is an example of an infectious disease. Non-living pathogens are used in inactivated vaccines to trigger an immune response, which effectively safeguards against illnesses like polio, hepatitis A, and influenza. For instance, an article from the Centers for Disease Control and Prevention, a US-based national public health agency, stated in November 2023 that there was a rise in tuberculosis patients in the USA from 8,320 in 2022 to 9,615 in 2023, amounting to an increase of 1,295 cases. Thus, the surge in infectious diseases is fueling the growth of the inactivated vaccine market.
Market Driver for Inactivated Vaccines: Growth of Inactivated Vaccines Market Propelled by Rising Immunization Initiatives
What key areas define the segmentation of the global inactivated vaccines market?
The inactivated vaccines market covered in this report is segmented –
1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
Subsegments:
1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine
2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp
Who are the dominant players expanding their reach in the inactivated vaccines market?
Major companies operating in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., .
How are evolving market trends shaping inactivated vaccines Strategies?
Prominent businesses operating in the domain of inactivated vaccines are leveraging new and sophisticated inactivated vaccines to maintain their dominance in the market. An inactivated vaccine consists of defunct virus particles, bacteria, or other pathogens that have been grown in a lab and then killed off to incapacitate their capability to induce diseases. For example, in January 2022, GSK PLC, a biopharmaceutical corporation in the UK, launched an innovative inactivated vaccine for protection against shingles called Shingrix. Shingrix, a non-live, recombinant subunit adjuvanted vaccine, is delivered intramuscularly in two doses. Originally, the vaccine was intended for people aged 50 and above, but it has now been approved for those 18 years and older who are at an increased risk of acquiring shingles due to immunodeficiency or immunosuppression triggered by a recognized disease or therapy.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13018
Which regions are emerging as leaders in the inactivated vaccines market?
North America was the largest region in the inactivated vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
Cancer Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report
Companion Animal Veterinary Vaccines Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
